Eversept Partners, LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Eversept Partners, LP disclosed 65 US equity positions worth $1.3bn in its Q3 2024 13F filing. The largest position was GSK at 12.7% of the reported book, followed by NTRA and VERA.
What did Eversept Partners, LP own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | GSK GSK PLC | Healthcare | 12.7% | $165.9m | 4,057,206 | – | |
| 2 | NTRA NATERA INC | Healthcare | 8.5% | $110.5m | 870,193 | – | |
| 3 | VERA VERA THERAPEUTICS INC | Healthcare | 7.0% | $90.6m | 2,050,157 | – | |
| 4 | INSM INSMED INC | Healthcare | 6.1% | $79.5m | 1,089,404 | – | |
| 5 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 6.1% | $79.0m | 4,105,313 | – | |
| 6 | RVTY REVVITY INC | Healthcare | 4.6% | $60.0m | 469,692 | – | |
| 7 | INSP INSPIRE MED SYS INC | Healthcare | 4.5% | $58.3m | 276,270 | – | |
| 8 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 4.5% | $58.3m | 3,234,638 | – | |
| 9 | CYH COMMUNITY HEALTH SYS INC NEW | Healthcare | 4.1% | $53.3m | 8,776,455 | – | |
| 10 | TECH BIO-TECHNE CORP | Healthcare | 4.1% | $53.0m | 663,573 | – | |
| 11 | HCA HCA HEALTHCARE INC | Healthcare | 4.0% | $52.5m | 129,084 | – | |
| 12 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 3.6% | $46.9m | 130,949 | – | |
| 13 | ZIMV ZIMVIE INC | 2.5% | $32.9m | 2,070,780 | – | ||
| 14 | HQY HEALTHEQUITY INC | Healthcare | 2.0% | $26.1m | 319,078 | – | |
| 15 | RGEN REPLIGEN CORP | Healthcare | 1.9% | $24.3m | 163,593 | – | |
| 16 | VTRS VIATRIS INC | Healthcare | 1.5% | $20.0m | 1,726,354 | – | |
| 17 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.5% | $20.0m | 445,204 | – | |
| 18 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.5% | $19.2m | 564,902 | – | |
| 19 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 1.4% | $18.9m | 471,355 | – | |
| 20 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 1.2% | $15.7m | 691,232 | – | |
| 21 | MNKD MANNKIND CORP | Healthcare | 1.0% | $12.5m | 1,992,504 | – | |
| 22 | BHC BAUSCH HEALTH COS INC | Healthcare | 1.0% | $12.5m | 1,530,914 | – | |
| 23 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.9% | $12.2m | 869,913 | – | |
| 24 | HUM HUMANA INC | Healthcare | 0.8% | $10.7m | 33,860 | – | |
| 25 | DHR DANAHER CORPORATION | Healthcare | 0.8% | $10.7m | 38,429 | – | |
| 26 | CNC CENTENE CORP DEL | Healthcare | 0.8% | $10.2m | 134,959 | – | |
| 27 | ELV ELEVANCE HEALTH INC | Healthcare | 0.8% | $10.1m | 19,465 | – | |
| 28 | FTRE FORTREA HLDGS INC | Healthcare | 0.7% | $9.2m | 457,967 | – | |
| 29 | ITCIEUR INTRA-CELLULAR THERAPIES INC | 0.7% | $9.1m | 124,491 | – | ||
| 30 | EOLS EVOLUS INC | Healthcare | 0.6% | $7.3m | 453,061 | – | |
| 31 | BHVN BIOHAVEN LTD | Healthcare | 0.5% | $6.6m | 132,537 | – | |
| 32 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 0.5% | $6.4m | 693,263 | – | |
| 33 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.5% | $6.4m | 1,841,989 | – | |
| 34 | BKD BROOKDALE SR LIVING INC | Healthcare | 0.4% | $5.8m | 861,268 | – | |
| 35 | NEWAMSTERDAM PHARMA COMPANY | 0.4% | $5.1m | 307,357 | – | ||
| 36 | FNAUSD PARAGON 28 INC | 0.4% | $5.0m | 749,213 | – | ||
| 37 | GOSS GOSSAMER BIO INC | Healthcare | 0.4% | $4.9m | 4,978,458 | – | |
| 38 | TSVT* 2SEVENTY BIO INC | 0.4% | $4.7m | 998,079 | – | ||
| 39 | KPTI KARYOPHARM THERAPEUTICS INC | Healthcare | 0.4% | $4.6m | 5,547,880 | – | |
| 40 | AVTR AVANTOR INC | Healthcare | 0.3% | $4.4m | 168,369 | – | |
| 41 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.3% | $4.1m | 535,405 | – | |
| 42 | ICLR ICON PLC | Healthcare | 0.3% | $3.9m | 13,668 | – | |
| 43 | KURA KURA ONCOLOGY INC | Healthcare | 0.3% | $3.8m | 192,398 | – | |
| 44 | MOH MOLINA HEALTHCARE INC | Healthcare | 0.3% | $3.6m | 10,588 | – | |
| 45 | MERUS N V | 0.3% | $3.4m | 68,258 | – | ||
| 46 | STAA STAAR SURGICAL CO | Healthcare | 0.3% | $3.4m | 91,199 | – | |
| 47 | PBYI PUMA BIOTECHNOLOGY INC | Healthcare | 0.3% | $3.3m | 1,293,257 | – | |
| 48 | ZLAB ZAI LAB LTD | Healthcare | 0.3% | $3.3m | 135,219 | – | |
| 49 | ZBIO ZENAS BIOPHARMA INC | 0.2% | $3.2m | 190,531 | – | ||
| 50 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.2% | $3.2m | 777,890 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.